The forecasted mortality rates for trachea, bronchus, or lung malignant neoplasms in Canadian females show a gradual annual increase from 2024 to 2028, starting at 9.81 thousand deaths and ending at 10.09 thousand. In 2023, this mortality rate stood at 9.74 thousand, indicating a consistent year-on-year increase over the subsequent years. The average compound annual growth rate (CAGR) during the forecast period is in alignment with this trend shown by a steady increment.

Future Trends to Watch for:

Monitor healthcare initiatives aimed at reducing smoking and air pollution, as these are primary risk factors for respiratory cancers.
Advancements in early detection and treatment could stabilize or potentially reduce mortality rates.
Demographic shifts, such as aging populations, could further impact these projections.